文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

加味柴胡疏肝散治疗功能性消化不良的系统评价:随机对照试验的荟萃分析。

Modified chaihu shugan powder for functional dyspepsia: meta-analysis for randomized controlled trial.

机构信息

Department of Clinical Pharmacy & Pharmacy Administration, West China Pharmacy School, Sichuan University, No. 17 Section 3 Renmin Nanlu, Chengdu, Sichuan 610041, China.

出版信息

Evid Based Complement Alternat Med. 2013;2013:791724. doi: 10.1155/2013/791724. Epub 2013 May 13.


DOI:10.1155/2013/791724
PMID:23762161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3666434/
Abstract

Context. Modified Chaihu Shugan powder (MCSP) is a popular traditional Chinese herbal formula for functional dyspepsia, which is revised from Chaihu Shugan San and recorded in a medical classic works of China. However, its role and effect in treating functional dyspepsia have not been well established. Objective. To assess the effect and safety of modified Chaihu Shugan powder for functional dyspepsia. Methods. We searched the published and unpublished studies up to August 2012. Only RCTs of modified Chaihu Shugan powder with or without prokinetic drugs versus prokinetic drugs in the patients diagnosed with functional dyspepsia were included. Results. Twenty-two clinical trials involving 1998 participants were included. There were evidences that modified Chaihu Shugan powder (RR = 1.20, 95%, CI 1.14 to 1.27) and modified Chaihu Shugan powder plus prokinetic drugs (RR = 1.18, 95%, CI 1.11 to 1.25) were significantly better treatment options than prokinetic drugs alone in improving symptoms. No serious adverse events were described in the included trials. Conclusions. This meta-analysis showed that modified Chaihu Shugan powder alone or in combination with prokinetic drugs might be more effective than prokinetic drugs alone. However, with poor methodological quality, all the included trials were at high risk of bias. Further large-scale high-quality trials are required for assessment.

摘要

背景:加味柴胡疏肝散(MCSP)是一种常用于治疗功能性消化不良的中药方剂,由柴胡疏肝散加减而成,收载于中国的一部医学经典著作中。然而,其治疗功能性消化不良的疗效和安全性尚未得到充分证实。目的:评估加味柴胡疏肝散治疗功能性消化不良的疗效和安全性。方法:我们检索了截至 2012 年 8 月发表和未发表的研究。仅纳入加味柴胡疏肝散与或不与促动力药联合治疗功能性消化不良患者的随机对照试验。结果:纳入了 22 项临床试验,共 1998 名参与者。有证据表明,加味柴胡疏肝散(RR=1.20,95%CI 1.14 至 1.27)和加味柴胡疏肝散联合促动力药(RR=1.18,95%CI 1.11 至 1.25)在改善症状方面明显优于单纯使用促动力药。纳入的试验中均未描述严重不良事件。结论:本荟萃分析显示,加味柴胡疏肝散单独使用或联合促动力药可能比单纯使用促动力药更有效。然而,由于方法学质量较差,所有纳入的试验均存在高度偏倚风险。需要进一步开展大规模高质量的试验来进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/64df75505e29/ECAM2013-791724.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/58a0fed8d7bf/ECAM2013-791724.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/132821585e47/ECAM2013-791724.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/cab7e4ccc46a/ECAM2013-791724.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/64df75505e29/ECAM2013-791724.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/58a0fed8d7bf/ECAM2013-791724.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/132821585e47/ECAM2013-791724.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/cab7e4ccc46a/ECAM2013-791724.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/3666434/64df75505e29/ECAM2013-791724.004.jpg

相似文献

[1]
Modified chaihu shugan powder for functional dyspepsia: meta-analysis for randomized controlled trial.

Evid Based Complement Alternat Med. 2013-5-13

[2]
Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia.

J Ethnopharmacol. 2011-5-13

[3]
Effect of Chaihu-Shugan-San on functional dyspepsia and gut microbiota: A randomized, double-blind, placebo-controlled trial.

J Ethnopharmacol. 2024-3-25

[4]
Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress.

Front Pharmacol. 2022-1-17

[5]
Meta-analysis of traditional Chinese medicine in treating functional dyspepsia of liver-stomach disharmony syndrome.

J Tradit Chin Med. 2012-12

[6]
Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance.

Biomed Pharmacother. 2018-5-7

[7]
Chaihu-Shugan-San, an oriental herbal preparation, for the treatment of chronic gastritis: a meta-analysis of randomized controlled trials.

J Ethnopharmacol. 2013-1-29

[8]
exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways.

Neural Regen Res. 2018-5

[9]
Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression.

J Ethnopharmacol. 2011-9-12

[10]
[Effect of modified chaihu shugan powder in treating patients with functional dyspepsia accompanied with depression].

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004-12

引用本文的文献

[1]
Comparative evaluation of two herbal formulas for gastrointestinal function and gut microbiota modulation in rats with loperamide-induced dyspepsia.

Sci Rep. 2025-8-25

[2]
Effects and mechanisms of traditional Chinese medicines on functional dyspepsia: A review.

Chin Herb Med. 2023-9-29

[3]
Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8.

Front Pharmacol. 2023-5-15

[4]
Complementary and alternative medicine for functional dyspepsia: An Asian perspective.

Medicine (Baltimore). 2022-9-2

[5]
Meranzin Hydrate Improves Depression-Like Behaviors and Hypomotility via Ghrelin and Neurocircuitry.

Chin J Integr Med. 2023-6

[6]
Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia.

Front Pharmacol. 2022-2-4

[7]
Effects of Chaihu-Shugan-San for reflux esophagitis: A protocol for systematic review and meta-analysis.

Medicine (Baltimore). 2020-12-4

[8]
Potential Molecular Mechanisms of Chaihu-Shugan-San in Treatment of Breast Cancer Based on Network Pharmacology.

Evid Based Complement Alternat Med. 2020-9-25

[9]
Herbal medicine Siho-sogan-san for functional dyspepsia: A protocol for a systematic review and meta-analysis.

Medicine (Baltimore). 2020-9-25

[10]
Simultaneous Determination of Five Components of Chaihu-Shugan-San in Beagle Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study after a Single Dose of Chaihu-Shugan-San.

J Anal Methods Chem. 2020-8-19

本文引用的文献

[1]
Review article: current treatment options and management of functional dyspepsia.

Aliment Pharmacol Ther. 2012-5-16

[2]
Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials.

J Ethnopharmacol. 2012-2-9

[3]
Asian consensus report on functional dyspepsia.

J Gastroenterol Hepatol. 2012-4

[4]
Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression.

J Ethnopharmacol. 2011-9-12

[5]
Influence of organic and functional dyspepsia on work productivity: the HEROES-DIP study.

Value Health. 2011

[6]
Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia.

J Ethnopharmacol. 2011-5-13

[7]
Genetic factors for functional dyspepsia.

J Gastroenterol Hepatol. 2011-4

[8]
Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia.

J Gastroenterol Hepatol. 2011-4

[9]
Current understanding of pathogenesis of functional dyspepsia.

J Gastroenterol Hepatol. 2011-4

[10]
Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia.

Intern Med. 2010

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索